Dilaudid-5 Side Effects
Generic Name: hydromorphone, hydromorphone hydrochloride
Please note - some side effects for Dilaudid-5 may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: compounding powder; injectable powder for injection; injectable solution; intravenous solution; oral capsule, extended release; oral liquid; oral tablet; oral tablet, extended release; rectal suppository
Nervous system side effects have included mental depression, respiratory depression (which is sometimes fatal), stupor, delirium, somnolence, agitation, increased intracranial pressure, and dysphoria. Myoclonus has also been reported.
Opioids may result in psychotic symptoms in some patients.
Other side effects have included withdrawal symptoms which have occurred following either abrupt cessation or fast tapering of narcotic analgesics and have included agitation, restlessness, anxiety, insomnia, tremor, abdominal cramps, blurred vision, vomiting, and sweating.
Cardiovascular side effects have occurred rarely and have included hypotension, shock, and arrhythmias.
Gastrointestinal side effects have included constipation, nausea, vomiting, biliary tract spasm, and dry mouth.
Dermatologic side effects including rashes and systemic contact dermatitis have been reported rarely.
Narcotic-induced rashes may be related to direct stimulation of histamine release.
Local side effects have included redness, swelling and pain which develop at the site of subcutaneous injection of hydromorphone. Two cases of fatal neurologic events have been reported following intravenous injection of hydromorphone. In one case, a known intravenous drug abuser injected two melted hydromorphone suppositories into the right antecubital vein and suffered a stroke. In the other, a known intravenous drug abuser injected ground hydromorphone tablets and presented in an akinetic mute state and later died.
Genitourinary side effects including urinary retention have been reported for other narcotic analgesics.Top
- Dilaudid-5 Advanced Consumer (Micromedex) - Includes Dosage Information
- Dilaudid Prescribing Information (FDA)
- Dilaudid MedFacts Consumer Leaflet (Wolters Kluwer)
- Dilaudid Consumer Overview
- Dilaudid-HP Prescribing Information (FDA)
- Dilaudid-HP Advanced Consumer (Micromedex) - Includes Dosage Information
- Dilaudid-HP MedFacts Consumer Leaflet (Wolters Kluwer)
- Exalgo Prescribing Information (FDA)
- Exalgo MedFacts Consumer Leaflet (Wolters Kluwer)
- Exalgo Consumer Overview
- Hydromorphone Prescribing Information (FDA)
- Hydromorphone Hydrochloride Monograph (AHFS DI)
- Palladone Prescribing Information (FDA)
- Palladone extended-release capsules MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.